Tom Butler
Chief Executive Officer presso BIOMEA FUSION, INC.
Patrimonio netto: 37 M $ in data 31/03/2024
Profilo
Mr. Thomas Butler is a Chairman & Chief Executive Officer at Biomea Fusion, Inc. and a Managing Member at Point Sur Investors LLC.
Prior to forming the General Partner, from June 2013 through October 2015, Mr. Butler managed Investor Relations at Pharmacyclics Inc., where he helped grow the company from a market cap of $6.74B to over $21B, which included the execution of one of the largest biotech acquisitions to date.
Prior to Pharmacyclics, Inc., he spent 6 years as a medicinal chemist at Gilead Sciences Inc. engaging in novel drug design and drug development for HCV polymerase and protease inhibitors.
He received his undergraduate degree from The California State University, a Master's degree in Organic Chemistry from the University of California, Santa Barbara and an MBA from the University of California, Los Angeles.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
BIOMEA FUSION INC
6.98% | 17/01/2024 | 2 493 407 ( 6.98% ) | 37 M $ | 31/03/2024 |
Posizioni attive di Tom Butler
Società | Posizione | Inizio |
---|---|---|
BIOMEA FUSION, INC. | Chief Executive Officer | 01/08/2017 |
Point Sur Investors LLC
Point Sur Investors LLC Investment ManagersFinance Point Sur Investors LLC provides investment advice. The private company is based in El Cerrito, CA and has subsidiaries in the United States. The company was founded in 2015 by Thomas Butler, Rainer M. Erdtmann. | Founder | 01/01/2015 |
Precedenti posizioni note di Tom Butler
Società | Posizione | Fine |
---|---|---|
PHARMACYCLICS, INC. | Investor Relations Contact | 01/01/2015 |
Formazione di Tom Butler
University of California, Los Angeles | Masters Business Admin |
The California State University | Undergraduate Degree |
University of California, Santa Barbara | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Point Sur Investors LLC
Point Sur Investors LLC Investment ManagersFinance Point Sur Investors LLC provides investment advice. The private company is based in El Cerrito, CA and has subsidiaries in the United States. The company was founded in 2015 by Thomas Butler, Rainer M. Erdtmann. | Finance |
Biomea Fusion, Inc. |
- Borsa valori
- Insiders
- Tom Butler